SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?


To: ~digs who wrote (22011)1/11/2005 8:20:00 AM
From: ~digs  Respond to of 48461
 
Jan. 11 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (Nasdaq: TGEN - News) and Sirna Therapeutics, Inc. (Nasdaq: RNAI - News) today announced that they have established a collaboration to develop novel therapies for the treatment of Huntington's Disease (HD), an incurable neurodegenerative disorder. The collaboration will combine Targeted Genetics' adeno-associated virus (AAV) delivery platform with Sirna's HD program and expertise in RNA silencing technologies. biz.yahoo.com